HIGHLIGHTS
- who: Dan Huang and colleagues from the Department of Child Health Care, Women`s (Hangzhou Maternity and Child Care, China Department of Endocrinology, The Children`s, Zhejiang University School of Medicine have published the research work: Recombinant Human Growth Hormone Therapy for Childhood Trichorhinophalangeal Syndrome Type I: A Case Report, in the Journal: Children 2022, 1447 of /2022/
- what: The authors report an 11-year-old Chinese boy with TRPS I with the typical clinical manifestations and a likely novel pathogenic nonsense variant in exon 4 of TPRS1, who had an excellent growth response to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.